Canton Strategic Holdings (CNTN) Change in Account Payables (2021 - 2026)
Canton Strategic Holdings posted quarterly Change in Account Payables of -$687963.0 for Q1 2026, down 1191.95% year-on-year from $63003.0 in Q1 2025, and down 303.3% on a QoQ basis from $338404.0 in Q4 2025.
Canton Strategic Holdings (CNTN) has 6 years of Change in Account Payables data on file, last reported at -$687963.0 in Q1 2026.
- For the quarter ending Q1 2026, Change in Account Payables fell 1191.95% year-over-year to -$687963.0; the trailing twelve-month figure through Mar 2026 stood at -$528489.0 (down 431.5% YoY), and the FY2025 full-year result was $222477.0, up 22.86% from the prior year.
- Change in Account Payables for Q1 2026 stood at -$687963.0, down from $338404.0 in the prior quarter.
- Across five years, Change in Account Payables topped out at $466532.0 in Q2 2023 and bottomed at -$687963.0 in Q1 2026.
- The 5-year median for Change in Account Payables is -$1720.0 (2023), against an average of -$27735.0.
- The widest annual swing landed in 2023, when Change in Account Payables soared 1330.11%; it then tumbled 1363.97% in 2025.
- A 5-year view of Change in Account Payables shows it stood at $58830.0 in 2022, then plunged by 491.16% to -$230118.0 in 2023, then jumped by 232.9% to $305827.0 in 2024, then advanced by 10.65% to $338404.0 in 2025, then sank by 303.3% to -$687963.0 in 2026.
- The last three Change in Account Payables figures came in at -$687963.0 (Q1 2026), $338404.0 (Q4 2025), and -$111356.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | -3.26 Mn |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 35.60 Mn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | - |
| 10 | Canton Strategic Holdings | 643.89 Mn | 602.36 Mn | - | -687,963.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -687,963.00 |
| Mar 31, 2026 | -687,963.00 |
| Dec 31, 2025 | 338,404.00 |
| Dec 31, 2025 | 338,404.00 |
| Sep 30, 2025 | -111,356.00 |
| Sep 30, 2025 | -111,356.00 |
| Jun 30, 2025 | -67,574.00 |
| Jun 30, 2025 | -67,574.00 |
| Mar 31, 2025 | 63,003.00 |
| Mar 31, 2025 | 63,003.00 |
| Dec 31, 2024 | 305,827.00 |
| Dec 31, 2024 | 305,827.00 |
| Sep 30, 2024 | 8,810.00 |
| Sep 30, 2024 | 8,810.00 |
| Jun 30, 2024 | -218,215.00 |
| Jun 30, 2024 | -218,215.00 |
| Mar 31, 2024 | 84,667.00 |
| Mar 31, 2024 | 84,667.00 |
| Dec 31, 2023 | -230,118.00 |
| Dec 31, 2023 | -230,118.00 |
| Sep 30, 2023 | -1,720.00 |
| Sep 30, 2023 | -1,720.00 |
| Jun 30, 2023 | 466,532.00 |
| Jun 30, 2023 | 466,532.00 |
| Mar 31, 2023 | -280,622.00 |
| Mar 31, 2023 | -280,622.00 |
| Dec 31, 2022 | 58,830.00 |
| Dec 31, 2022 | 58,830.00 |
| Sep 30, 2022 | 336,146.00 |
| Sep 30, 2022 | 336,146.00 |
| Jun 30, 2022 | -37,926.00 |
| Jun 30, 2022 | -37,926.00 |
| Mar 31, 2022 | -498,220.00 |
| Mar 31, 2022 | -498,220.00 |
| Dec 31, 2021 | 140,616.00 |
| Dec 31, 2021 | 140,616.00 |
| Sep 30, 2021 | 61,168.00 |
| Sep 30, 2021 | 61,168.00 |
| Jun 30, 2021 | 319,880.00 |
| Jun 30, 2021 | 319,880.00 |
| Mar 31, 2021 | 59,183.00 |
| Mar 31, 2021 | 59,183.00 |